2011
DOI: 10.1002/jat.1696
|View full text |Cite
|
Sign up to set email alerts
|

An intravenous exposure mouse model for prediction of potential drug‐sensitization using reporter antigens popliteal lymph node assay

Abstract: Immune-mediated drug hypersensitivity is a particularly concerning health-safety issue among clinicians given its unpredictability and potentially life-threatening effects, especially with exposure to intravenous drugs. Therefore, the development of intravenous drug-exposure models for drug-hazard assessments has garnered increasing interest in recent years. In this study, we used reporter antigens popliteal lymph node assay to investigate the potential value of intravenous exposure to a selected variety of al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 35 publications
0
8
0
Order By: Relevance
“…These include the mouse popliteal lymph node assay (PLNA) (20)(21)(22), the mouse ear-swelling test (23)(24)(25), the guinea pig (GP) maximization test (GPMT), the GP occluded patch test (Buehler's test) (26,27) and the murine local lymph node assay (MLLA) (26). In fact, the standard guinea pig assays were shown to be useless in predicting systemic hypersensitivity (28).…”
Section: In Vitro Tests For Carpamentioning
confidence: 98%
“…These include the mouse popliteal lymph node assay (PLNA) (20)(21)(22), the mouse ear-swelling test (23)(24)(25), the guinea pig (GP) maximization test (GPMT), the GP occluded patch test (Buehler's test) (26,27) and the murine local lymph node assay (MLLA) (26). In fact, the standard guinea pig assays were shown to be useless in predicting systemic hypersensitivity (28).…”
Section: In Vitro Tests For Carpamentioning
confidence: 98%
“…In this work, two studies were included in meta-analysis of PLNA parameters; one proved a positive reaction by using an intravenous mouse model [14, 35], while another showed a negative result by subcutaneous administration. The inconsistent results of PLN cellularity and IgG1 AFCs were pooled by meta-analysis and the pooled results showed that CGA might significantly increase PLN cellularity and induce IgG1 AFCs formation.…”
Section: Discussionmentioning
confidence: 99%
“…With the wide application in China, the safety issues of TCMIs are becoming increasingly critical in recent years. One research indicated that TCMIs accounted for 66.7% of adverse reactions in traditional Chinese medicines [14]. Furthermore, it is estimated that 90% of these adverse reactions, especially the systemic safety of sensitization, are related to TCMIs containing CGA [15].…”
Section: Introductionmentioning
confidence: 99%
“…Based on the RA-PLNA, a particularly useful tool for the systemic sensitizing potential assessment, 29 our previous studies have demonstrated that an intravenous exposure mouse model, which was validated by 3 positive and 1 negative compounds, appears to be a potentially useful tool for drug-induced hypersensitivity screening via intravenous exposure. 21 In this study, by using the mouse model, the potential sensitization of CGA and its isomers via intravenous exposure were further determined. Our results showed that, CGA and its isomers (except CA and QA) may significantly enhance the weight indexes and cell numbers in PLN compared with the control.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, by using an intravenous mouse model that we have developed in our previous study, 21 the primary issue addressed in this study was to explore the sensitization potential of CGA. Furthermore, we hypothesize that CGA or its isomers, including caffeic acid (CA), quinic acid (QA), crypto-chlorogenic acid (crypto-CGA), iso-chlorogenic acid A (iso-CGA A), and iso-chlorogenic acid B ([iso-CGA B] for structures see Figure 1), have a structure-activity relationship in immunostimulation.…”
Section: Introductionmentioning
confidence: 99%